Market Research Logo

Ambit Biosciences Corporation – Product Pipeline Review – H2 2011

68 Pages Global Markets Direct November 28, 2011 SKU: GMD6692747

Ambit Biosciences Corporation - Product Pipeline Review - H2 2011

Summary

Global Market Direct’s pharmaceuticals report, “Ambit Biosciences Corporation - Product Pipeline Review - H2 2011” provides data on the Ambit Biosciences Corporation’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Ambit Biosciences Corporation’s corporate website, SEC filings, investor presentations and featured press releases, both from Ambit Biosciences Corporation and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope
  • Ambit Biosciences Corporation - Brief Ambit Biosciences Corporation overview including business description, key information and facts, and its locations and subsidiaries.
  • Review of current pipeline of Ambit Biosciences Corporation human therapeutic division.
  • Overview of pipeline therapeutics across various therapy areas.
  • Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
  • Product profiles for late stage and clinical stage products of Ambit Biosciences Corporation with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
  • Recent updates of the Ambit Biosciences Corporation’s pipeline in the last quarter.
  • Key discontinued and dormant projects.
  • Latest news and deals relating to the products.
Reasons to buy
  • Evaluate Ambit Biosciences Corporation’s strategic position with total access to detailed information on its product pipeline.
  • Assess the growth potential of Ambit Biosciences Corporation in its therapy areas of focus.
  • Identify new drug targets and therapeutic classes in the Ambit Biosciences Corporation’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
  • Exploit collaboration and partnership opportunities with Ambit Biosciences Corporation.
  • Avoid Intellectual Property Rights related issues.
  • Explore the dormant and discontinued projects of Ambit Biosciences Corporation and identify potential opportunities in those areas.

Show Full Description


Show Table of Contents



Ambit Biosciences Corporation – Product Pipeline Review – H2 2011

Global Markets Direct
November 28, 2011

Search inside this report



Pricing & Delivery

Online Download
$500
Global Site License
$1,500

Didn't find what you are looking for?

Let us find it for you. One of our knowledgeable research assistants will work with you to find exactly the right research to answer your questions:

US: 800.298.5699 International: +1.240.747.3093 Or leave us a message and we'll call you back!

Receive bi-weekly email alerts for new market research.



CTA Image

Download our free eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.


Download CTA

Share this report